Chang CC - Search Results

1

C-X-C motif chemokine ligand 12-C-X-C chemokine receptor type 4 signaling axis in cancer and the development of chemotherapeutic molecules.

Yen JH, Chang CC, Hsu HJ, Yang CH, Mani H, Liou JW. Yen JH, et al. Among authors: chang cc. Tzu Chi Med J. 2024 May 27;36(3):231-239. doi: 10.4103/tcmj.tcmj_52_24. eCollection 2024 Jul-Sep. Tzu Chi Med J. 2024. PMID: 38993827 Free PMC article. Review.

2

Peptides derived from CXCL8 based on in silico analysis inhibit CXCL8 interactions with its receptor CXCR1.

Jiang SJ, Liou JW, Chang CC, Chung Y, Lin LF, Hsu HJ. Jiang SJ, et al. Among authors: chang cc. Sci Rep. 2015 Dec 22;5:18638. doi: 10.1038/srep18638. Sci Rep. 2015. PMID: 26689258 Free PMC article.

3

A Sequence in the loop domain of hepatitis C virus E2 protein identified in silico as crucial for the selective binding to human CD81.

Chang CC, Hsu HJ, Yen JH, Lo SY, Liou JW. Chang CC, et al. PLoS One. 2017 May 8;12(5):e0177383. doi: 10.1371/journal.pone.0177383. eCollection 2017. PLoS One. 2017. PMID: 28481946 Free PMC article.

4

A potential peptide derived from cytokine receptors can bind proinflammatory cytokines as a therapeutic strategy for anti-inflammation.

Jiang SJ, Tsai PI, Peng SY, Chang CC, Chung Y, Tsao HH, Huang HT, Chen SY, Hsu HJ. Jiang SJ, et al. Among authors: chang cc. Sci Rep. 2019 Feb 19;9(1):2317. doi: 10.1038/s41598-018-36492-z. Sci Rep. 2019. PMID: 30783144 Free PMC article.

5

Targeting of interleukin-10 receptor by a potential human interleukin-10 peptide efficiently blocks interleukin-10 pathway-dependent cell proliferation.

Chang CC, Liu CD, Pan SF, Huang WH, Peng CW, Hsu HJ. Chang CC, et al. Tzu Chi Med J. 2020 Jan 17;32(3):245-253. doi: 10.4103/tcmj.tcmj_237_19. eCollection 2020 Jul-Sep. Tzu Chi Med J. 2020. PMID: 32955521 Free PMC article.

6

Valine-279 Deletion-Mutation on Arginine Vasopressin Receptor 2 Causes Obstruction in G-Protein Binding Site: A Clinical Nephrogenic Diabetes Insipidus Case and Its Sub-Molecular Pathogenic Analysis.

Chen MC, Hsiao YC, Chang CC, Pan SF, Peng CW, Li YT, Liu CD, Liou JW, Hsu HJ. Chen MC, et al. Among authors: chang cc. Biomedicines. 2021 Mar 15;9(3):301. doi: 10.3390/biomedicines9030301. Biomedicines. 2021. PMID: 33804115 Free PMC article.

7

The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma.

Liu CD, Chang CC, Huang WH. Liu CD, et al. Among authors: chang cc. Tzu Chi Med J. 2020 Dec 4;33(3):257-262. doi: 10.4103/tcmj.tcmj_141_20. eCollection 2021 Jul-Sep. Tzu Chi Med J. 2020. PMID: 34386363 Free PMC article. Review.

8

Combinatorial Virtual Screening Revealed a Novel Scaffold for TNKS Inhibition to Combat Colorectal Cancer.

Chang CC, Pan SF, Wu MH, Cheng CT, Su YR, Jiang SJ, Hsu HJ. Chang CC, et al. Biomedicines. 2022 Jan 10;10(1):143. doi: 10.3390/biomedicines10010143. Biomedicines. 2022. PMID: 35052822 Free PMC article.

9

A Multitarget Therapeutic Peptide Derived From Cytokine Receptors Based on in Silico Analysis Alleviates Cytokine-Stimulated Inflammation.

Chang CC, Peng SY, Tsao HH, Huang HT, Lai XY, Hsu HJ, Jiang SJ. Chang CC, et al. Front Pharmacol. 2022 Mar 10;13:853818. doi: 10.3389/fphar.2022.853818. eCollection 2022. Front Pharmacol. 2022. PMID: 35370629 Free PMC article.

10

Hepatitis C virus core protein: Not just a nucleocapsid building block, but an immunity and inflammation modulator.

Mani H, Yen JH, Hsu HJ, Chang CC, Liou JW. Mani H, et al. Among authors: chang cc. Tzu Chi Med J. 2021 Sep 24;34(2):139-147. doi: 10.4103/tcmj.tcmj_97_21. eCollection 2022 Apr-Jun. Tzu Chi Med J. 2021. PMID: 35465281 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,537 results

Search Page

Filters